ArticleWorld journal of psychiatry2025
Risk factors for anxiety and depression in patients with atopic dermatitis and their impact on prognosis.
Article in World journal of psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Prevalence and determinants of anxiety and depression in adult patients with atopic dermatitis in Tanzania.Skin health and disease · 2026Article
- The Therapeutic Potential of Polyphenols in Modulating Barrier Lipids, Microbiome Interactions, and Inflammatory Pathways in Atopic Dermatitis.Nutrients · 2026Review
- Ameliorative Effects of Liquiritin Carbomer Gel on Dinitrofluorobenzene-Induced Atopic Dermatitis in Mice.Gels (Basel, Switzerland) · 2026Article
- Factors Influencing Self-Management Behaviors in Patients with Atopic Dermatitis and Intervention Strategies: A Narrative Review.Patient preference and adherence · 2026Review
- Skin Barrier Repair and Nursing Care in Patients with Atopic Dermatitis: A Narrative Review.International journal of general medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtopic dermatitis (AD) is a chronic inflammatory skin disease characterized by visible lesions that can lead to anxiety and depression. These psychological impacts may severely affect the physical and mental health and the overall quality of life of the affected individuals.
aimTo identify the risk factors for anxiety and depression among patients with AD and to assess their influence on prognosis.
methodsA cross-sectional study was conducted in 273 patients with AD who visited Shanghai Jinshan Tinglin Hospital between July 2021 and June 2023. Data were collected using standardized instruments, including the general information questionnaire, hospital anxiety and depression scale, scoring AD index, and dermatology life quality index.
resultsAmong the evaluated patients, 24.5% had symptoms of anxiety, and 19.8% had symptoms of depression. Independent risk factors for anxiety included lower education level [odds ratio (OR) = 0.338, 95% confidence interval (CI): 0.183-0.625], increased number of medical visits (OR = 2.300, 95%CI: 1.234-4.255), sleep disorders (OR = 2.013, 95%CI: 1.032-3.923), and allergic rhinitis (OR = 2.052, 95%CI: 1.097-3.839). Factors for depression included more severe pruritus (OR = 6.837, 95%CI: 1.330-35.132), higher number of medical visits (OR = 2.979, 95%CI: 1.430-6.205), sleep disorders (OR = 2.245, 95%CI: 1.033-5.024), and asthma (OR = 2.208, 95%CI: 1.003-4.859). Dermatology life quality index scores correlated positively with anxiety, depression, scoring AD index, sleep disorders, number of visits, and intensity of pruritus (
conclusionIn patients with AD, anxiety and depression are associated with educational level, frequency of medical visits, sleep disorders, allergic rhinitis, pruritus, and asthma, all of which exacerbate symptoms and reduce quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.